R. Lozano, M. Naghavi, and K. Foreman, Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study, Lancet, vol.380, pp.2095-2128, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00827612

A. M. Miniño, J. Xu, and K. D. Kochanek, Deaths: preliminary data for, Natl Vital Stat Rep, vol.59, pp.1-52, 2008.

J. L. López-campos, M. Ruiz-ramos, and J. B. Soriano, Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis, Lancet Respir Med, vol.2, pp.54-62, 2014.

C. J. Murray and A. D. Lopez, Measuring the global burden of disease, N Engl J Med, vol.369, pp.448-457, 2013.

M. J. Thun, B. D. Carter, and D. Feskanich, 50-year trends in smoking-related mortality in the United States, N Engl J Med, vol.368, pp.351-364, 2013.

A. J. Guarascio, S. M. Ray, and C. K. Finch, The clinical and economic burden of chronic obstructive pulmonary disease in the USA, Clinicoecon Outcomes Res, vol.5, pp.235-245, 2013.

B. R. Celli, W. Macnee, and A. Agusti, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper, Eur Respir J, vol.23, pp.932-946, 2004.

J. Vestbo, S. S. Hurd, and A. G. Agustí, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary, Am J Respir Crit Care Med, vol.187, pp.347-365, 2013.

J. O'reilly, M. M. Jones, and J. Parnham, Guideline Development Group. Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance, BMJ, vol.340, p.3134, 2010.

B. L. Rostron, C. M. Chang, and T. F. Pechacek, Estimation of cigarette smoking-attributable morbidity in the United States, JAMA Intern Med, vol.174, pp.1922-1928, 2014.

K. Barnett, S. W. Mercer, and M. Norbury, Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study, Lancet, vol.380, pp.37-43, 2012.

P. Jones, M. Miravitlles, and T. Van-der-molen, Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement, Int J Chron Obstruct Pulmon Dis, vol.7, pp.697-709, 2012.

N. Roche, J. Gaillat, and M. Garre, Acute respiratory illness as a trigger for detecting chronic bronchitis in adults at risk of COPD: a primary care survey, Prim Care Respir J, vol.19, pp.371-377, 2010.

C. G. Cote, C. Casanova, and J. M. Marín, Validation and comparison of reference equations for the 6-min walk distance test, Eur Respir J, vol.31, pp.571-578, 2008.

T. Oga, K. Nishimura, and M. Tsukino, Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status, Am J Respir Crit Care Med, vol.167, pp.544-549, 2003.

H. O. Coxson and S. Lam, Quantitative assessment of the airway wall using computed tomography and optical coherence tomography, Proc Am Thorac Soc, vol.6, pp.439-443, 2009.

S. J. Copley, A. U. Wells, and N. L. Müller, Thin-section CT in obstructive pulmonary disease: discriminatory value, Radiology, vol.223, pp.812-819, 2002.

H. O. Coxson, J. Mayo, and S. Lam, New and current clinical imaging techniques to study chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.180, pp.588-597, 2009.

R. G. Barr, E. A. Berkowitz, and F. Bigazzi, COPDGene CT Workshop Group. A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation, COPD, vol.9, pp.151-159, 2012.

C. J. Galbán, M. K. Han, and J. L. Boes, Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression, Nat Med, vol.18, pp.1711-1715, 2012.

A. Christe, J. Charimo-torrente, and K. Roychoudhury, Accuracy of low-dose computed tomography (CT) for detecting and characterizing the most common CT-patterns of pulmonary disease, Eur J Radiol, vol.82, pp.142-150, 2013.

P. J. Castaldi, S. Estépar, R. Mendoza, and C. S. , Distinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokers, Am J Respir Crit Care Med, vol.188, pp.1083-1090, 2013.

H. O. Coxson, J. Leipsic, and G. Parraga, Using pulmonary imaging to move COPD beyond FEV1, Am J Respir Crit Care Med, vol.190, pp.135-144, 2014.

J. P. De-torres, J. M. Marín, and C. Casanova, Lung cancer in patients with chronic obstructive pulmonary disease -incidence and predicting factors, Am J Respir Crit Care Med, vol.184, pp.913-919, 2011.

J. A. Hardie, A. S. Buist, and W. M. Vollmer, Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers, Eur Respir J, vol.20, pp.1117-1122, 2002.

I. Cerveri, A. G. Corsico, and S. Accordini, Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes, Thorax, vol.63, pp.1040-1045, 2008.

S. P. Bhatt, J. C. Sieren, and M. T. Dransfield, COPDGene Investigators. Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction, Thorax, vol.69, pp.409-414, 2014.

A. C. Carlsson, P. Wändell, and U. Ösby, High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden -a challenge for public health, BMC Public Health, vol.13, pp.670-678, 2013.

P. O. Bridevaux, M. W. Gerbase, and N. M. Probst-hensch, Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD, Thorax, vol.63, pp.768-774, 2008.

U. S. , Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, vol.148, pp.529-534, 2008.

M. Ferrer, J. Alonso, and J. Morera, The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Chronic obstructive pulmonary disease stage and health-related quality of life, Ann Intern Med, vol.127, pp.1072-1079, 1997.

M. Friedman, C. W. Serby, and S. S. Menjoge, Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD, Chest, vol.115, pp.635-641, 1999.

P. S. Burge, P. M. Calverley, and P. W. Jones, Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial, BMJ, vol.320, pp.1297-1303, 2000.

N. A. Dewan, S. Rafique, and B. Kanwar, Acute exacerbation of COPD: factors associated with poor treatment outcome, Chest, vol.117, pp.662-671, 2000.

N. R. Anthonisen, E. C. Wright, and J. E. Hodgkin, Prognosis in chronic obstructive pulmonary disease, Am Rev Respir Dis, vol.133, pp.14-20, 1986.

B. R. Celli, R. J. Halbert, and S. Isonaka, Population impact of different definitions of airway obstruction, Eur Respir J, vol.22, pp.268-273, 2003.

M. B. Parshall, R. M. Schwartzstein, and L. Adams, American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea, Am J Respir Crit Care Med, vol.185, pp.435-452, 2012.

A. M. Schols, J. Slangen, and L. Volovics, Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.157, pp.1791-1797, 1998.

C. Landbo, E. Prescott, and P. Lange, Prognostic value of nutritional status in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.160, pp.1856-1861, 1999.

D. A. Mahler, J. Ward, and L. A. Waterman, Patient-reported dyspnea in COPD reliability and association with stage of disease, Chest, vol.136, pp.1473-1479, 2009.

K. Nishimura, T. Izumi, and M. Tsukino, Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD, Chest, vol.121, pp.1434-1440, 2002.

J. Garcia-aymerich, P. Lange, and M. Benet, Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study, Thorax, vol.61, pp.772-778, 2006.

B. R. Celli, C. G. Cote, and J. M. Marin, The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease, N Engl J Med, vol.350, pp.1005-1012, 2004.

C. G. Cote, V. M. Pinto-plata, and J. M. Marin, The modified BODE index: validation with mortality in COPD, Eur Respir J, vol.32, pp.1269-1274, 2008.

J. J. Soler-cataluña, M. A. Martínez-garcía, and L. S. Sánchez, Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients, Respir Med, vol.103, pp.692-699, 2009.

J. M. Marin, I. Alfageme, and P. Almagro, Multicomponent indices to predict survival in COPD: the COCOMICS study, Eur Respir J, vol.42, pp.323-332, 2013.

B. R. Celli, N. Locantore, and J. Yates, ECLIPSE Investigators. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.185, pp.1065-1072, 2012.

M. A. Puhan, J. Garcia-aymerich, and M. Frey, Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index, Lancet, vol.374, pp.704-711, 2009.

R. C. Jones, G. C. Donaldson, and N. H. Chavannes, Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index, Am J Respir Crit Care Med, vol.180, pp.1189-1195, 2009.

P. Almagro, J. B. Soriano, and F. J. Cabrera, Working Group on COPD, Spanish Society of Internal Medicine. Shortand medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index, Chest, vol.145, pp.972-980, 2014.

P. Lange, J. L. Marott, and J. Vestbo, Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population, Am J Respir Crit Care Med, vol.186, pp.975-981, 2012.

J. B. Soriano, I. Alfageme, and P. Almagro, Distribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classification, Chest, vol.143, pp.694-702, 2013.

A. Johannessen, R. M. Nilsen, and M. Storebø, Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization, Am J Respir Crit Care Med, vol.188, pp.51-59, 2013.

M. Divo, C. Cote, and J. P. De-torres, Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.186, pp.155-161, 2012.

A. Agustí, J. A. Barberà, and E. Wouters, Lungs, bone marrow, and adipose tissue. A network approach to the pathobiology of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.188, pp.1396-1406, 2013.

G. C. Donaldson, T. Seemungal, and A. Bhowmik, Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease, Thorax, vol.57, pp.847-852, 2002.

J. Vestbo, L. D. Edwards, and P. D. Scanlon, ECLIPSE Investigators. Changes in forced expiratory volume in 1 second over time in COPD, N Engl J Med, vol.365, pp.1184-1192, 2011.

A. Agusti, P. M. Calverley, and B. Celli, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort, Respir Res, vol.11, pp.122-136, 2010.

N. Freimer and C. Sabatti, The human phenome project, Nat Genet, vol.34, pp.15-21, 2003.

M. K. Han, A. Agusti, and P. M. Calverley, Chronic obstructive pulmonary disease phenotypes: the future of COPD, Am J Respir Crit Care Med, vol.182, pp.598-604, 2010.

J. M. Drazen and L. M. Fabbri, Ageing and multimorbidity, Eur Respir J, vol.44, p.557, 2014.

R. Faner, T. Cruz, and A. López-giraldo, Network medicine, multimorbidity and the lung in the elderly, Eur Respir J, vol.44, pp.775-788, 2014.

M. J. Divo, C. H. Martinez, and D. M. Mannino, Ageing and the epidemiology of multimorbidity, Eur Respir J, vol.44, pp.1055-1068, 2014.

A. R. Patel, G. C. Donaldson, and A. J. Mackay, The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD, Chest, vol.141, pp.851-857, 2012.

D. M. Mannino, D. Thorn, and A. Swensen, Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD, Eur Respir J, vol.32, pp.962-969, 2008.

D. O. Wilson, J. K. Leader, and C. R. Fuhrman, Quantitative computed tomography analysis, airflow obstruction, and lung cancer in the Pittsburgh lung screening study, J Thorac Oncol, vol.6, pp.1200-1205, 2011.

P. M. Calverley, J. A. Anderson, and B. Celli, TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease, N Engl J Med, vol.356, pp.775-789, 2007.

L. E. Vanfleteren, M. A. Spruit, and M. Groenen, Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.187, pp.728-735, 2013.

M. Roca, A. Verduri, and L. Corbetta, Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease, Eur J Clin Invest, vol.43, pp.510-521, 2013.

G. C. Donaldson, J. R. Hurst, and C. J. Smith, Increased risk of myocardial infarction and stroke following exacerbation of COPD, Chest, vol.137, pp.1091-1097, 2010.

R. P. Bowler, V. Kim, and E. Regan, COPDGene Investigators. Prediction of acute respiratory disease in current and former smokers with and without COPD, Chest, vol.146, pp.941-950, 2014.

W. C. Tan, J. Bourbeau, and P. Hernandez, CanCOLD Collaborative Research Group. Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study, Thorax, vol.69, pp.709-717, 2014.

J. M. Marin, J. B. Soriano, and S. J. Carrizo, Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome, Am J Respir Crit Care Med, vol.182, pp.325-331, 2010.

J. E. Repine, A. Bast, and I. Lankhorst, Oxidative Stress Study Group. Oxidative stress in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.156, pp.341-357, 1997.

E. G. Tzortzaki and N. M. Siafakas, A hypothesis for the initiation of COPD, Eur Respir J, vol.34, pp.310-315, 2009.

S. Sethi and T. F. Murphy, Infection in the pathogenesis and course of chronic obstructive pulmonary disease, N Engl J Med, vol.359, pp.2355-2365, 2008.

A. A. Pragman, H. B. Kim, and C. S. Reilly, The lung microbiome in moderate and severe chronic obstructive pulmonary disease, PLoS ONE, vol.7, p.47305, 2012.

M. G. Cosio, M. Saetta, and A. Agusti, Immunologic aspects of chronic obstructive pulmonary disease, N Engl J Med, vol.360, pp.2445-2454, 2009.

I. K. Demedts, T. Demoor, and K. R. Bracke, Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema, Respir Res, vol.7, p.53, 2006.

R. Faner, M. Rojas, and W. Macnee, Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, vol.186, pp.306-313, 2012.

Q. Yang, M. J. Underwood, and M. K. Hsin, Dysfunction of pulmonary vascular endothelium in chronic obstructive pulmonary disease: basic considerations for future drug development, Curr Drug Metab, vol.9, pp.661-667, 2008.

A. Rab, S. M. Rowe, and S. V. Raju, Cigarette smoke and CFTR: implications in the pathogenesis of COPD, Am J Physiol Lung Cell Mol Physiol, vol.305, pp.530-541, 2013.

M. Saetta, D. Stefano, A. Turato, and G. , CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.157, pp.822-826, 1998.

S. I. Rennard, Inflammation and repair processes in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.160, pp.12-16, 1999.

V. I. Peinado, J. A. Barberá, and P. Abate, Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.159, pp.1605-1611, 1999.

R. Rodriguez-roisin and W. Macnee, Pathophysiology of chronic obstructive pulmonary disease, Eur Respir Monogr, vol.3, pp.107-126, 1998.

T. C. O&apos;shaughnessy, T. W. Ansari, and N. C. Barnes, Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1, Am J Respir Crit Care Med, vol.155, pp.852-857, 1997.

K. Matsuba, J. L. Wright, and B. R. Wiggs, The changes in airways structure associated with reduced forced expiratory volume in one second, Eur Respir J, vol.2, pp.834-839, 1989.

D. E. O&apos;donnell, S. M. Revill, and K. A. Webb, Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.164, pp.770-777, 2001.

P. Jha and R. Peto, Global effects of smoking, of quitting, and of taxing tobacco, N Engl J Med, vol.370, pp.60-68, 2014.

N. R. Anthonisen, J. E. Connett, and R. P. Murray, Smoking and lung function of Lung Health Study participants after 11 years, Am J Respir Crit Care Med, vol.166, pp.675-679, 2002.

G. Parkes, T. Greenhalgh, and M. Griffin, Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial, BMJ, vol.336, pp.598-600, 2008.

M. Bednarek, D. Gorecka, and J. Wielgomas, Smokers with airway obstruction are more likely to quit smoking, Thorax, vol.61, pp.869-873, 2006.

G. Stratelis, S. Mölstad, and P. Jakobsson, The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD, Scand J Prim Health Care, vol.24, pp.133-139, 2006.

D. Kotz, G. Wesseling, and M. Huibers, Efficacy of confronting smokers with airflow limitation for smoking cessation, Eur Respir J, vol.33, pp.754-762, 2009.

C. A. Jiménez-ruiz, F. Masa, and M. Miravitlles, Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD, Chest, vol.119, pp.1365-1370, 2001.

D. Tashkin, R. Kanner, and W. Bailey, Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial, Lancet, vol.357, pp.1571-1575, 2001.

D. P. Tashkin, S. Rennard, and J. T. Hays, Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial, Chest, vol.139, pp.591-599, 2011.

P. Tønnesen, K. Mikkelsen, and L. Bremann, Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support, Chest, vol.130, pp.334-342, 2006.

E. J. Wagena, R. M. Van-der-meer, and R. J. Ostelo, The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review, Respir Med, vol.98, pp.805-815, 2004.

I. Wilson, Depression in the patient with COPD, Int J Chron Obstruct Pulmon Dis, vol.1, pp.61-64, 2006.

N. A. Rigotti, A. L. Pipe, and N. L. Benowitz, Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial, Circulation, vol.121, pp.221-229, 2010.

B. M. Kuehn, Updated US smoking cessation guideline advises counseling, combining therapies, JAMA, vol.299, p.2736, 2008.

S. D. Shah, L. A. Wilken, and S. R. Winkler, Systematic review and meta-analysis of combination therapy for smoking cessation, J Am Pharm Assoc, vol.48, pp.659-665, 2003.

M. B. Steinberg, S. Greenhaus, and A. C. Schmelzer, Triple-combination pharmacotherapy for medically ill smokers: a randomized trial, Ann Intern Med, vol.150, pp.447-454, 2009.

M. E. Piper, S. S. Smith, and T. R. Schlam, A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies, Arch Gen Psychiatry, vol.66, pp.1253-1262, 2009.

E. F. Ellerbeck, J. D. Mahnken, and A. P. Cupertino, Effect of varying levels of disease management on smoking cessation: a randomized trial, Ann Intern Med, vol.150, pp.437-446, 2009.

M. C. Fiore, C. R. Jaen, and T. B. Baker, Update. Clinical Practice Guidelines. Rockville, US Department of Health and Human Services, 2008.

T. J. Crowley, M. J. Macdonald, and M. I. Walter, Behavioral anti-smoking trial in chronic obstructive pulmonary disease patients, Psychopharmacology (Berl), vol.119, pp.193-204, 1995.

J. Etter, C. Bullen, and A. D. Flouris, Electronic nicotine delivery systems: a research agenda, Tob Control, vol.20, pp.243-248, 2011.

J. Etter and C. Bullen, Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy, Addiction, vol.106, pp.2017-2028, 2011.

M. L. Goniewicz, E. O. Lingas, and P. Hajek, Patterns of electronic cigarette use and user beliefs about their safety and benefits: an internet survey, Drug Alcohol Rev, vol.32, pp.133-140, 2013.

J. F. Bertholon, M. H. Becquemin, and I. Annesi-maesano, Electronic cigarettes: a short review, Respiration, vol.86, pp.433-438, 2013.

D. E. Schraufnagel, F. Blasi, and M. B. Drummond, Electronic cigarettes: a position statement of the forum of international respiratory societies, Am J Respir Crit Care Med, vol.190, pp.611-618, 2014.

A. S. Buist, G. J. Sexton, and J. M. Nagy, The effect of smoking cessation and modification on lung function, Am Rev Respir Dis, vol.114, pp.115-122, 1976.

C. Jiménez-ruiz, S. Solano, and S. A. Viteri, Harm reduction-a treatment approach for resistant smokers with tobacco-related symptoms, Respiration, vol.69, pp.452-455, 2002.

S. I. Rennard, D. Daughton, and J. Fujita, Short-term smoking reduction is associated with reduction in measures of lower respiratory tract inflammation in heavy smokers, Eur Respir J, vol.3, pp.752-759, 1990.

M. S. Simmons, J. E. Connett, and M. A. Nides, Smoking reduction and the rate of decline in FEV1: results from the Lung Health Study, Eur Respir J, vol.25, pp.1011-1017, 2005.

J. R. Hughes and M. J. Carpenter, Does smoking reduction increase future cessation and decrease disease risk? A qualitative review, Nicotine Tob Res, vol.8, pp.739-749, 2006.

R. Boyle, L. Solberg, and M. Fiore, Use of electronic health records to support smoking cessation, Cochrane Database Syst Rev, vol.12, p.8743, 2011.

J. M. Tetrault, K. Crothers, and B. A. Moore, Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review, Arch Intern Med, vol.167, pp.221-228, 2007.

D. P. Tashkin, B. Celli, and S. Senn, UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease, N Engl J Med, vol.359, pp.1543-1554, 2008.

C. R. Jenkins, P. W. Jones, and P. M. Calverley, Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study, Respir Res, vol.10, p.59, 2009.

P. R. Burgel, J. L. Paillasseur, and D. Dusser, UPLIFT® Study Investigators. Tiotropium might improve survival in subjects with COPD at high risk of mortality, Respir Res, vol.15, p.64, 2014.

B. R. Celli, N. E. Thomas, and J. A. Anderson, Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study, Am J Respir Crit Care Med, vol.178, pp.332-338, 2008.

M. Decramer, B. Celli, and S. Kesten, UPLIFT investigators. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial, Lancet, vol.374, pp.1171-1178, 2009.

P. R. Burgel, J. L. Paillasseur, and B. Peene, Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality, PLoS ONE, vol.7, p.51048, 2012.

E. D. Bateman, C. Feldman, and J. O&apos;brien, Guideline for the management of chronic obstructive pulmonary disease (COPD): 2004 revision, S Afr Med J, vol.94, pp.559-575, 2004.

J. A. Wedzicha, M. Decramer, and T. A. Seemungal, The role of bronchodilator treatment in the prevention of exacerbations of COPD, Eur Respir J, vol.40, pp.1545-1554, 2012.

M. K. Han, N. Tayob, and S. Murray, Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy, Am J Respir Crit Care Med, vol.189, pp.1503-1508, 2014.

J. Chong, C. Karner, and P. Poole, Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, vol.9, p.9157, 2012.

K. F. Rabe, L. M. Fabbri, and E. Israel, Effect of ADRB2 polymorphism on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial, Lancet Respir Med, vol.2, pp.44-53, 2014.

M. L. Decramer, K. R. Chapman, and R. Dahl, INVIGORATE investigators. Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study, Lancet Respir Med, vol.1, pp.524-533, 2013.

P. M. Calverley, R. A. Stockley, and T. A. Seemungal, Investigating New Standards for Prophylaxis in Reduction of Exacerbations (INSPIRE) Investigators. Reported pneumonia in patients with COPD: findings from the INSPIRE study, Chest, vol.139, pp.505-512, 2011.

C. Crim, P. M. Calverley, and J. A. Anderson, Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results, Eur Respir J, vol.34, pp.641-647, 2009.

J. A. Wedzicha, P. M. Calverley, and T. A. Seemungal, INSPIRE Investigators. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide, Am J Respir Crit Care Med, vol.177, pp.19-26, 2008.

S. D. Aaron, K. L. Vandemheen, and D. Fergusson, Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial, Ann Intern Med, vol.146, pp.545-555, 2007.

J. A. Wedzicha, M. Decramer, and J. H. Ficker, Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study, Lancet Respir Med, vol.1, pp.199-209, 2013.

P. M. Short, P. A. Williamson, and D. H. Elder, The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting ?-agonist therapy in COPD, Chest, vol.141, pp.81-86, 2012.

K. S. Jung, H. Y. Park, and S. Y. Park, Korean Academy of Tuberculosis and Respiratory Diseases study group; Korea Chronic Obstructive Pulmonary Disease study group. Comparison of tiotropium plus fluticasone propionate/ salmeterol with tiotropium in COPD: a randomized controlled study, Respir Med, vol.106, pp.382-389, 2012.

H. Magnussen, B. Disse, and R. Rodriguez-roisin, Withdrawal of inhaled glucocorticoids and exacerbations of COPD, N Engl J Med, vol.371, pp.1285-1294, 2014.

J. W. Dodd, L. Hogg, and J. Nolan, The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study, Thorax, vol.66, pp.425-429, 2011.

P. W. Jones, G. Harding, and P. Berry, Development and first validation of the COPD Assessment Test, Eur Respir J, vol.34, pp.648-654, 2009.

P. W. Jones, G. Harding, and I. Wiklund, Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation, Chest, vol.142, pp.134-140, 2012.

J. Vestbo, J. A. Anderson, and P. M. Calverley, Adherence to inhaled therapy, mortality and hospital admission in COPD, Thorax, vol.64, pp.939-943, 2009.

E. L. Toy, N. U. Beaulieu, and J. M. Mchale, Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs, Respir Med, vol.105, pp.435-441, 2011.

P. Barnestein-fonseca, J. Leiva-fernández, and F. Vidal-españa, Efficacy and safety of a multifactor intervention to improve therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): protocol for the ICEPOC study, Trials, vol.12, p.40, 2011.

A. S. Melani, M. Bonavia, and V. Cilenti, Gruppo Educazionale Associazione Italiana Pneumologi Ospedalieri. Inhaler mishandling remains common in real life and is associated with reduced disease control, Respir Med, vol.105, pp.930-938, 2011.

W. Vincken, P. R. Dekhuijzen, P. Barnes, and . Group, The ADMIT series -Issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPD, Prim Care Respir J, vol.19, pp.10-20, 2010.

B. L. Laube, H. M. Janssens, and F. De-jongh, European Respiratory Society; International Society for Aerosols in Medicine. What the pulmonary specialist should know about the new inhalation therapies, Eur Respir J, vol.37, pp.1308-1331, 2011.

M. J. Sevenoaks and R. A. Stockley, Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity-a common inflammatory phenotype?, Respir Res, vol.7, p.70, 2006.

P. J. Barnes, New anti-inflammatory targets for chronic obstructive pulmonary disease, Nat Rev Drug Discov, vol.12, pp.543-559, 2013.

G. G. Brusselle, G. F. Joos, and K. R. Bracke, New insights into the immunology of chronic obstructive pulmonary disease, Lancet, vol.378, pp.1015-1026, 2011.

S. I. Rennard, C. Fogarty, and S. Kelsen, COPD Investigators. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.175, pp.926-934, 2007.

C. E. Brightling, E. R. Bleecker, R. A. Panettieri, and . Jr, Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomized, double-blind, placebo-controlled, phase 2a study, Lancet Respir Med, vol.2, pp.891-901, 2014.

J. Chong, P. Poole, and B. Leung, Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, vol.5, p.2309, 2011.

D. J. Powrie, T. M. Wilkinson, and G. C. Donaldson, Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD, Eur Respir J, vol.30, pp.472-478, 2007.

D. A. Lomas, D. A. Lipson, and B. E. Miller, Losmapimod Study Investigators. An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease, J Clin Pharmacol, vol.52, pp.416-424, 2012.

H. Watz, H. Barnacle, and B. F. Hartley, Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial, Lancet Respir Med, vol.2, pp.63-72, 2014.

P. J. Barnes and I. M. Adcock, Glucocorticoid resistance in inflammatory diseases, Lancet, vol.373, pp.1905-1917, 2009.

M. Bafadhel, L. Davies, and P. M. Calverley, Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis, Eur Respir J, vol.44, pp.789-791, 2014.

M. Bafadhel, S. Mckenna, and S. Terry, Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial, Am J Respir Crit Care Med, vol.186, pp.48-55, 2012.

H. Ortega, H. Li, and R. Suruki, Cluster analysis and characterization of response to mepolizumab. A step closer to personalized medicine for patients with severe asthma, Ann Am Thorac Soc, vol.11, pp.1011-1017, 2014.

I. D. Pavord, S. Korn, and P. Howarth, Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial, Lancet, vol.380, pp.651-659, 2012.

S. Hodge, G. Hodge, and H. Jersmann, Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.178, pp.139-148, 2008.

M. Yamaya, A. Azuma, and H. Takizawa, Macrolide effects on the prevention of COPD exacerbations, Eur Respir J, vol.40, pp.485-494, 2012.

R. K. Albert, J. Connett, and W. C. Bailey, COPD Clinical Research Network. Azithromycin for prevention of exacerbations of COPD, N Engl J Med, vol.365, pp.689-698, 2011.

T. A. Seemungal, T. M. Wilkinson, and J. R. Hurst, Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations, Am J Respir Crit Care Med, vol.178, pp.1139-1147, 2008.

W. A. Ray, K. T. Murray, and K. Hall, Azithromycin and the risk of cardiovascular death, N Engl J Med, vol.366, pp.1881-1890, 2012.

W. A. Ray, K. T. Murray, and S. Meredith, Oral erythromycin and the risk of sudden death from cardiac causes, N Engl J Med, vol.351, pp.1089-1096, 2004.

H. Svanström, B. Pasternak, and A. Hviid, Use of azithromycin and death from cardiovascular causes, N Engl J Med, vol.368, pp.1704-1712, 2013.

S. Sethi, P. W. Jones, and M. S. Theron, PULSE Study group. Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial, Respir Res, vol.11, p.10, 2010.

L. Marin, P. Colombo, and M. Bebawy, Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management, Expert Opin Drug Deliv, vol.8, pp.1205-1220, 2011.

R. P. Young, R. Hopkins, and T. E. Eaton, Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence, Postgrad Med J, vol.85, pp.414-421, 2009.

M. Bando, T. Miyazawa, and H. Shinohara, An epidemiological study of the effects of statin use on airflow limitation in patients with chronic obstructive pulmonary disease, Respirology, vol.17, pp.493-498, 2012.

K. Bartziokas, A. I. Papaioannou, and M. Minas, Statins and outcome after hospitalization for COPD exacerbation: a prospective study, Pulm Pharmacol Ther, vol.24, pp.625-631, 2011.

S. Janda, K. Park, and J. M. Fitzgerald, Statins in COPD: a systematic review, Chest, vol.136, pp.734-743, 2009.

C. C. Dobler, K. K. Wong, and G. B. Marks, Associations between statins and COPD: a systematic review, BMC Pulm Med, vol.9, p.32, 2009.

T. M. Lee, C. C. Chen, and H. N. Shen, Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension, Clin Sci, vol.116, pp.497-505, 2009.

G. J. Criner, J. E. Connett, and S. D. Aaron, COPD Clinical Research Network; Canadian Institutes of Health Research. Simvastatin for the prevention of exacerbations in moderate-to-severe COPD, N Engl J Med, vol.370, pp.2201-2210, 2014.

L. C. Price, D. Lowe, and H. S. Hosker, UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation, Thorax, vol.61, pp.837-842, 2006.

F. H. Rutten, N. P. Zuithoff, and E. Hak, Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease, Arch Intern Med, vol.170, pp.880-887, 2010.

Y. Nussbaumer-ochsner and K. F. Rabe, Systemic manifestations of COPD, Chest, vol.139, pp.165-173, 2011.

M. A. Spruit, S. J. Singh, and C. Garvey, statement: key concepts and advances in pulmonary rehabilitation, Am J Respir Crit Care Med, vol.188, pp.13-64, 2013.

D. S. Vieira, F. Maltais, and J. Bourbeau, Home-based pulmonary rehabilitation in chronic obstructive pulmonary disease patients, Curr Opin Pulm Med, vol.16, pp.134-143, 2010.

F. Maltais, J. Bourbeau, and S. Shapiro, Chronic Obstructive Pulmonary Disease Axis of Respiratory Health Network, Fonds de recherche en santé du Québec. Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial, Ann Intern Med, vol.149, pp.869-878, 2008.

C. R. Van-wetering, M. Hoogendoorn, and S. J. Mol, Short-and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial, Thorax, vol.65, pp.7-13, 2010.

C. R. Van-wetering, M. Hoogendoorn, and R. Broekhuizen, Efficacy and costs of nutritional rehabilitation in muscle-wasted patients with chronic obstructive pulmonary disease in a community-based setting: a prespecified subgroup analysis of the INTERCOM trial, J Am Med Dir Assoc, vol.11, pp.179-187, 2010.

M. A. Puhan, E. Gimeno-santos, and M. Scharplatz, Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, vol.10, p.5305, 2011.

R. Casaburi, D. Kukafka, and C. B. Cooper, Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD, Chest, vol.127, pp.809-817, 2005.

, Report of the Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema, Lancet, vol.1, pp.681-686, 1981.

, Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial, Ann Intern Med, vol.93, pp.391-398, 1980.

D. Górecka, K. Gorzelak, and P. Sliwi?ski, Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia, Thorax, vol.52, pp.674-679, 1997.

A. Chaouat, E. Weitzenblum, and R. Kessler, A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients, Eur Respir J, vol.14, pp.1002-1008, 1999.

T. L. Petty, R. E. Stanford, and T. A. Neff, Continuous oxygen therapy in chronic airway obstruction. Observations on possible oxygen toxicity and survival, Ann Intern Med, vol.75, pp.361-367, 1971.

G. A. West and P. Primeau, Nonmedical hazards of long-term oxygen therapy, Respir Care, vol.28, pp.906-912, 1983.

A. Murabit and E. E. Tredget, Review of burn injuries secondary to home oxygen, J Burn Care Res, vol.33, pp.212-217, 2012.

L. Brochard, J. Mancebo, and M. Wysocki, Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease, N Engl J Med, vol.333, pp.817-822, 1995.

J. Bott, M. P. Carroll, and J. H. Conway, Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease, Lancet, vol.341, pp.1555-1557, 1993.

N. Kramer, T. J. Meyer, and J. Meharg, Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure, Am J Respir Crit Care Med, vol.151, pp.1799-1806, 1995.

P. K. Plant, J. L. Owen, and M. W. Elliott, Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial, Lancet, vol.355, pp.1931-1935, 2000.

S. Nava and N. Hill, Non-invasive ventilation in acute respiratory failure, Lancet, vol.374, pp.250-259, 2009.

S. P. Bhatt, M. W. Peterson, and J. S. Wilson, Noninvasive positive pressure ventilation in subjects with stable COPD: a randomized trial, Int J Chron Obstruct Pulmon Dis, vol.8, pp.581-589, 2013.

B. Lamia, A. Cuvelier, and J. Benichou, Bénéfices de la ventilation non invasive à domicile au décours d'une insuffisance respiratoire aiguë hypercapnique chez les patients BPCO. Étude contrôlée randomisée multicentrique. Étude Non Invasive Ventilation in Obstructive Lung Disease (Nivold) [A multi-centre randomised controlled trial of domiciliary non-invasive ventilation vs long-term oxygen therapy in survivors of acute hypercapnic respiratory failure due to COPD. Non-invasive ventilation

, Rev Mal Respir, vol.29, pp.1141-1148, 2012.

E. Clini, C. Sturani, and A. Rossi, The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients, Eur Respir J, vol.20, pp.529-538, 2002.

F. M. Struik, R. T. Sprooten, and H. A. Kerstjen, Nocturnal non-invasive ventilation in COPD patients with prolonged hypercapnia after ventilatory support for acute respiratory failure: a randomised, controlled, parallel-group study, Thorax, vol.69, pp.826-834, 2014.

F. M. Struik, Y. Lacasse, and R. S. Goldstein, Nocturnal noninvasive positive pressure ventilation in stable COPD: a systematic review and individual patient data meta-analysis, Respir Med, vol.108, pp.329-337, 2014.

T. Kohnlein, W. Windisch, and D. Kohler, Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial, Lancet Respir Med, vol.2, pp.698-705, 2014.

B. F. Meyers and G. A. Patterson, Chronic obstructive pulmonary disease. 10: Bullectomy, lung volume reduction surgery, and transplantation for patients with chronic obstructive pulmonary disease, Thorax, vol.58, pp.634-638, 2003.

A. Fishman, F. Martinez, and K. Naunheim, National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema, N Engl J Med, vol.348, pp.2059-2073, 2003.

S. D. Ramsey, K. Berry, and R. Etzioni, National Emphysema Treatment Trial Research Group. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema, N Engl J Med, vol.348, pp.2092-2102, 2003.

F. C. Sciurba, A. Ernst, and F. J. Herth, VENT Study Research Group. A randomized study of endobronchial valves for advanced emphysema, N Engl J Med, vol.363, pp.1233-1244, 2010.

J. D. Christie, L. B. Edwards, and A. Y. Kucheryavaya, International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012, J Heart Lung Transplant, vol.31, pp.1073-1086, 2012.

G. Thabut, P. Ravaud, and J. D. Christie, Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.177, pp.1156-1163, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00282520

S. Lahzami, P. O. Bridevaux, and P. M. Soccal, Survival impact of lung transplantation for COPD, Eur Respir J, vol.36, pp.74-80, 2010.

A. Eskander, T. K. Waddell, and M. E. Faughnan, BODE index and quality of life in advanced chronic obstructive pulmonary disease before and after lung transplantation, J Heart Lung Transplant, vol.30, pp.1334-1341, 2011.

J. B. Orens, M. Estenne, and S. Arcasoy, Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation, J Heart Lung Transplant, vol.25, pp.745-755, 2006.

G. Thabut, J. D. Christie, and P. Ravaud, Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data, Lancet, vol.371, pp.744-751, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00282487

Q. Wang, C. A. Rogers, and R. S. Bonser, Assessing the benefit of accepting a single lung offer now compared with waiting for a subsequent double lung offer, Transplantation, vol.91, pp.921-926, 2011.

J. C. Munson, J. D. Christie, and S. D. Halpern, The societal impact of single versus bilateral lung transplantation for chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.184, pp.1282-1288, 2011.

A. M. Schols and H. R. Gosker, The pathophysiology of cachexia in chronic obstructive pulmonary disease, Curr Opin Support Palliat Care, vol.3, pp.282-287, 2009.

R. Mostert, A. Goris, and C. Weling-scheepers, Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease, Respir Med, vol.94, pp.859-867, 2000.

E. C. Creutzberg, A. Schols, and F. Bothmer-quaedvlieg, Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function, Eur J Clin Nutr, vol.52, pp.396-401, 1998.

R. Hallin, C. Janson, and R. H. Arnardottir, Relation between physical capacity, nutritional status and systemic inflammation in COPD, Clin Respir J, vol.5, pp.136-142, 2011.

P. F. Collins, R. J. Stratton, and M. Elia, Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis, Am J Clin Nutr, vol.95, pp.1385-1395, 2012.

I. M. Ferreira, D. Brooks, and Y. Lacasse, Nutritional support for individuals with COPD: a meta-analysis, Chest, vol.117, pp.672-678, 2000.

P. Laveneziana and P. Palange, ERS Research Seminar Faculty. Physical activity, nutritional status and systemic inflammation in COPD, Eur Respir J, vol.40, pp.522-529, 2012.

C. Hanson, E. P. Rutten, and E. F. Wouters, Diet and vitamin D as risk factors for lung impairment and COPD, Transl Res, vol.162, pp.219-236, 2013.

S. M. Bjerk, B. D. Edgington, and T. S. Rector, Supplemental vitamin D and physical performance in COPD: a pilot randomized trial, Int J Chron Obstruct Pulmon Dis, vol.8, pp.97-104, 2013.

J. Bourbeau, M. Julien, and F. Maltais, Chronic Obstructive Pulmonary Disease axis of the Respiratory Network Fonds de la Recherche en Santé du Québec. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention, Arch Intern Med, vol.163, pp.585-591, 2003.

C. Hernandez, A. Casas, and J. Escarrabill, CHRONIC project. Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients, Eur Respir J, vol.21, pp.58-67, 2003.

J. Garcia-aymerich, C. Hernandez, and A. Alonso, Effects of an integrated care intervention on risk factors of COPD readmission, Respir Med, vol.101, pp.1462-1469, 2007.

A. Casas, T. Troosters, and J. Garcia-aymerich, members of the CHRONIC Project. Integrated care prevents hospitalisations for exacerbations in COPD patients, Eur Respir J, vol.28, pp.123-130, 2006.

K. L. Rice, N. Dewan, and H. E. Bloomfield, Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial, Am J Respir Crit Care Med, vol.182, pp.890-896, 2010.

V. S. Fan, J. M. Gaziano, and R. Lew, A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial, Ann Intern Med, vol.156, pp.673-683, 2012.

F. S. Ram, J. A. Wedzicha, and J. Wright, Hospital at home for patients with acute exacerbations of chronic obstructive pulmonary disease: systematic review of evidence, BMJ, vol.329, p.315, 2004.

T. A. Seemungal and J. A. Wedzicha, Integrated care: a new model for COPD management?, Eur Respir J, vol.28, pp.4-6, 2006.

T. Vontetsianos, P. Giovas, and T. Katsaras, Telemedicine-assisted home support for patients with advanced chronic obstructive pulmonary disease: preliminary results after nine-month follow-up, J Telemed Telecare, vol.11, pp.86-88, 2005.

M. Vitacca, L. Bianchi, and A. Guerra, Tele-assistance in chronic respiratory failure patients: a randomised clinical trial, Eur Respir J, vol.33, pp.411-418, 2009.

C. Sicotte, G. Paré, and S. Morin, Effects of home telemonitoring to support improved care for chronic obstructive pulmonary diseases, Telemed J E Health, vol.17, pp.95-103, 2011.

H. Pinnock, J. Hanley, and L. Mccloughan, Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial, BMJ, vol.347, p.6070, 2013.

E. Knauft, E. L. Nielsen, and R. A. Engelberg, Barriers and facilitators to end-of-life care communication for patients with COPD, Chest, vol.127, pp.2188-2196, 2005.

D. H. Au, E. M. Udris, and S. D. Fihn, Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer, Arch Intern Med, vol.166, pp.326-331, 2006.

J. R. Curtis, R. A. Engelberg, and E. L. Nielsen, Patient-physician communication about end-of-life care for patients with severe COPD, Eur Respir J, vol.24, pp.200-205, 2004.

D. H. Au, E. M. Udris, and R. A. Engelberg, A randomized trial to improve communication about end-of-life care among patients with COPD, Chest, vol.141, pp.726-735, 2012.

M. T. Claessens, J. Lynn, and Z. Zhong, Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT, J Am Geriatr Soc, vol.48, pp.146-153, 2000.

P. White, S. White, and P. Edmonds, Palliative care or end-of-life care in advanced chronic obstructive pulmonary disease: a prospective community survey, Br J Gen Pract, vol.61, pp.362-370, 2011.

D. J. Janssen, M. A. Spruit, and N. H. Uszko-lencer, Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure, J Palliat Med, vol.14, pp.735-743, 2011.

M. Gott, C. Gardiner, and N. Small, Barriers to advance care planning in chronic obstructive pulmonary disease, Palliat Med, vol.23, pp.642-648, 2009.

D. J. Janssen, J. R. Curtis, and D. H. Au, Patient-clinician communication about end-of-life care for Dutch and US patients with COPD, Eur Respir J, vol.38, pp.268-276, 2011.

L. A. Fleisher, J. A. Beckman, and K. A. Brown, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)

, Heart Rhythm Society; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society for Vascular Surgery. ACC/ AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Echocardiography, vol.116, pp.418-499, 2007.

D. Poldermans, J. J. Bax, and O. Schouten, Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo Study Group. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?, J Am Coll Cardiol, vol.48, pp.964-969, 2006.

D. Poldermans, O. Schouten, and R. Vidakovic, DECREASE Study Group. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study, J Am Coll Cardiol, vol.49, pp.1763-1769, 2007.

E. O. Mcfalls, H. B. Ward, and T. E. Moritz, Coronary-artery revascularization before elective major vascular surgery, N Engl J Med, vol.351, pp.2795-2804, 2004.

, Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery, Thorax, vol.56, pp.89-108, 2001.

G. L. Colice, S. Shafazand, and J. P. Griffin, Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidence-based clinical practice guidelines, Chest, vol.132, pp.161-177, 2007.

A. Mandra, D. Simi?, and V. Stevanovi?, Preoperative considerations for patients with chronic obstructive pulmonary disease, Acta Chir Iugosl, vol.58, pp.71-75, 2011.

A. Brunelli, M. Refai, and F. Xiumé, Performance at symptom-limited stair-climbing test is associated with increased cardiopulmonary complications, mortality, and costs after major lung resection, Ann Thorac Surg, vol.86, pp.240-247, 2008.

T. Win, A. D. Tasker, and A. M. Groves, Ventilation-perfusion scintigraphy to predict postoperative pulmonary function in lung cancer patients undergoing pneumonectomy, AJR Am J Roentgenol, vol.187, pp.1260-1265, 2006.

M. K. Ferguson, L. Little, and L. Rizzo, Diffusing capacity predicts morbidity and mortality after pulmonary resection, J Thorac Cardiovasc Surg, vol.96, pp.894-900, 1988.

J. S. Wang, Relationship of predicted postoperative product to postpneumonectomy cardiopulmonary complications, J Chin Med Assoc, vol.66, pp.643-654, 2003.

J. S. Wang, Relationship of carbon monoxide pulmonary diffusing capacity to postoperative cardiopulmonary complications in patients undergoing pneumonectomy, Kaohsiung J Med Sci, vol.19, pp.437-446, 2003.

C. T. Bolliger, P. Jordan, and M. Solèr, Exercise capacity as a predictor of postoperative complications in lung resection candidates, Am J Respir Crit Care Med, vol.151, pp.1472-1480, 1995.

D. A. Holden, T. W. Rice, and K. Stelmach, Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection, Chest, vol.102, pp.1774-1779, 1992.

J. Markos, B. P. Mullan, and D. R. Hillman, Preoperative assessment as a predictor of mortality and morbidity after lung resection, Am Rev Respir Dis, vol.139, pp.902-910, 1989.

R. J. Pierce, J. M. Copland, and K. Sharpe, Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality, Am J Respir Crit Care Med, vol.150, pp.947-955, 1994.

K. Nakahara, Y. Monden, and K. Ohno, A method for predicting postoperative lung function and its relation to postoperative complications in patients with lung cancer, Ann Thorac Surg, vol.39, pp.260-265, 1985.

K. Nakahara, K. Ohno, and J. Hashimoto, Prediction of postoperative respiratory failure in patients undergoing lung resection for lung cancer, Ann Thorac Surg, vol.46, pp.549-552, 1988.

M. D. Taylor, D. J. Lapar, and J. M. Isbell, Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer, J Thorac Cardiovasc Surg, vol.147, pp.738-744, 2014.

A. Brunelli, A. Refai, M. Monteverde, and M. , Predictors of early morbidity after major lung resection in patients with and without airflow limitation, Ann Thorac Surg, vol.74, pp.999-1003, 2002.

A. Edvardsen, A. Akerø, and J. A. Hardie, High prevalence of respiratory symptoms during air travel in patients with COPD, Respir Med, vol.105, pp.50-56, 2011.

S. Ahmedzai, I. M. Balfour-lynn, and T. Bewick, British Thoracic Society Standards of Care Committee. Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations, Thorax, vol.66, pp.1-30, 2011.

L. M. Seccombe and M. J. Peters, Oxygen supplementation for chronic obstructive pulmonary disease patients during air travel, Curr Opin Pulm Med, vol.12, pp.140-144, 2006.

A. Akerø, C. C. Christensen, and A. Edvardsen, Pulse oximetry in the preflight evaluation of patients with chronic obstructive pulmonary disease, Aviat Space Environ Med, vol.79, pp.518-524, 2008.

A. Akerø, A. Edvardsen, and C. C. Christensen, COPD and air travel: oxygen equipment and preflight titration of supplemental oxygen, Chest, vol.140, pp.84-90, 2011.

M. S. Abdool-gaffar, A. Ambaram, and G. M. Ainslie, Guideline for the management of chronic obstructive pulmonary disease-2011 update, S Afr Med J, vol.101, pp.63-73, 2011.

C. C. Christensen, M. S. Ryg, and A. Edvardsen, Relationship between exercise desaturation and pulmonary haemodynamics in COPD patients, Eur Respir J, vol.24, pp.580-586, 2004.